ArticleBMC musculoskeletal disorders2025
Predictors of mid-term outcomes in 334 developmental dysplasia hips treated with total hip arthroplasty.
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- 'THA for DDH: replacement principles and techniques - femoral side'.EFORT open reviews · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
aimsUnder the trend of gradual morphological evolution of different types of developmental dysplasia of the hip (DDH), this study aimed to investigate objective factors to predict complications in DDH patients after total hip arthroplasty (THA).
methodsFrom July 2010 to December 2019, 241 DDH patients (334 hips) received THA. The minimum follow-up time was five years. Univariable and multivariable logistic regression analyses were used to determine predictors of complications.
resultsThe incidence of periprosthetic fractures was 1.5% and BMI was independently associated with it (odds ratio [OR]: 0.698; 95% confidence interval [CI]: 0.505-0.966); acetabular prosthesis position was independently associated with limp (34.1%) (OR: 2.369; 95% CI: 1.267-4.432); height (OR: 0.003; 95% CI: 0.000-0.579), short left leg (OR: 0.203; 95% CI: 0.066-0.621) and femoral prosthesis distal size (OR: 0.778; 95% CI: 0.617-0.981) were associated with knee valgus (19.5%); limb length discrepancy (OR: 1.378; 95% CI: 1.034-1.835) and femoral head size (OR: 1.329; 95% CI: 1.053-1.678) were associated with knee pain (2.4%); femoral prosthesis (S-Rom) (OR: 0.045; 95% CI: 0.004-0.507) and acetabular prosthesis position (OR: 23.381; 95% CI: 1.297-421.580) were associated with thigh pain (distal femoral prosthesis) (2.1%); femoral prosthesis was associated with hip abnormal noise (5.4%) (S-Rom: OR: 0.034; 95% CI: 0.004-0.313; Corail: OR: 0.077; 95% CI: 0.008-0.726).
conclusionTall, higher BMI, short left leg, lower limb length discrepancy, anatomical acetabulum, friendly femoral prosthesis, smaller femoral head size, or larger femoral prosthesis distal size were found to have lower complications, but the preoperative Crowe type was not confirmed as a risk factor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.